Atopic Dermatitis
Latest News
Today’s top news highlights: Primary care practices struggle, Americans split on COVID-19 vaccine
COVID-19 puts primary care practice in peril, and social distancing takes a toll on seniors.
Latest News
Biologic approved for atopic dermatitis in children
Dupilumab becomes the only biologic medicine indicated for children with moderate-to-severe AD.
Conference Coverage
Expert discusses her approach to using systemic agents in children and adolescents with severe skin disease
In the clinical opinion of Kaiane A....
Conference Coverage
Dupilumab hits the mark for severe AD in younger children
About a third of patients had clear or nearly clear skin after 4 months.
Conference Coverage
Routinely screen for depression in atopic dermatitis
Symptoms of anxiety/depression are an indication to intensify atopic dermatitis therapy.
Conference Coverage
New topicals coming for pediatric atopic dermatitis
LAHAINA, HAWAII – Novel noncorticosteroid topicals will fill an unmet need in atopic dermatitis.
Conference Coverage
Dupilumab approval sought for AD under age 12
LAHAINA, HAWAII – First biologic approved for atopic dermatitis is under study down to age 2 years.
Pediatric Dermatology Consult
A 7-month-old male presents with perioral rash and fever
From the Journals
Emollients didn’t prevent atopic dermatitis in high-risk infants
Moisturizers and dietary interventions early in life did not reduce rates of atopic dermatitis in two large clinical trials.
Conference Coverage
Dupilumab for severe AD: Expert advocates continuous treatment
LAHAINA, HAWAII – “Be very careful about stopping.” – Dr. Andrew Blauvelt.
Conference Coverage
Consider allergic contact dermatitis in children with AD with disease flares, new rash
ORLANDO – “The take-home message here is that pediatric contact dermatitis is common, much more common than a lot of people realize.”